DNA testing for Patients in USA
“Uncovering Periodic Paralysis” is a no-cost genetic testing program offered by Strongbridge Biopharma for those who qualify. Although genetic testing can confirm a suspected diagnosis, the absence of a genetic mutation does not rule out diagnosis of the disease. The Periodic Paralysis Panel includes testing of the three genes that are most commonly-associated with periodic paralysis: SCN4A, CACNA1S, and KCNJ2.
“There is a growing awareness of periodic paralysis and access to tests such as this may help shorten the diagnostic journey for patients,” said Steve Cannon M.D., PhD, neurologist and professor of Physiology at UCLA. “Access to more reliable genetic testing will empower medical professionals with the right information to facilitate improved clinical management of the disease.”
To qualify for the program individuals must:
- Be at least 18 years old
- Have experienced more than one occurrence of episodic muscle weakness/paralysis attacks, or episodic pain after attacks
- Episodes provoked by at least one of the common triggers for hyperkalemic or hypokalemic periodic paralysis, e.g. potassium, carbohydrates, rest after exercise, cold exposure, or stress.
- Have your physician complete the application form here: Invitae | Uncovering Periodic Paralysis
For more information about the program, please visit “Uncovering Periodic Paralysis“: